<DOC>
	<DOCNO>NCT02984410</DOCNO>
	<brief_summary>Oropharyngeal Squamous Cell Carcinoma ( OPSCC ) arise soft palate , tonsil , base tongue , pharyngeal wall , vallecula . Most patient early stage OPSCC usually cure . Treatment early stage OPSCC successfully achieve primary surgery include neck dissection , indicate , definitive radiotherapy . The current standard treatment OPSCC therefore base either surgery and/or radiotherapy , associate comparable , high tumor control rate different side effect profile technical constraint . In order decrease potential morbidity surgery , transoral approach develop within last decade , include transoral robotic surgery ( TORS ) , transoral laser microsurgery ( TLM ) conventional transoral technique . On hand , patient head neck cancer treat IMRT experience significant improvement cause specific survival ( CSS ) compare patient treat non-IMRT technique thus suggest IMRT may beneficial term patient 's outcomes toxicity profile . It yet unclear however , one new technique superior term function preservation . Given functional outcome importance swallow function , preservation swallow thus major importance . The main objective study assess compare patient-reported swallow function first year randomization either IMRT TOS among patient early stage OPSCC .</brief_summary>
	<brief_title>Study Assessing The `` Best '' Radiotherapy v `` Best '' Surgery Patients With Oropharyngeal Carcinoma</brief_title>
	<detailed_description>Eligible patient randomize 1 1 radiotherapy ( Arm 1 ) surgery ( Arm 2 ) . ARM 1 : Radiotherapy Intensity modulate radiation therapy ( IMRT ) Simultaneous integrate boost ( SIB ) apply patient arm . PTV prescription tumor high risk area deliver daily 5 day per week total dose 66-70Gy 2 Gy/fraction 6 week , elective/prophylactic mucosal nodal area receive total dose 54.25- 54.45 Gy 33-35 fraction 1.55-1.65 Gy 6 week . ARM 2 : Surgery Trans-oral surgery ( trans-oral approach trans-oral laser microsurgery conventional trans-oral surgery ( OPC tonsil ) trans-oral robotic surgery ) apply patient arm . A surgical margin define clear ( R0 ) , find &gt; /=3mm final specimen ( except deep margin tonsillar resection , either R1 R0 ) , define close , 1- &lt; 3mm , consider involve ( R1 ) , &lt; 1mm final specimen . Clearly define marginal biopsy require TOS-technique . Trans-oral re-resections require case R1 close-margin convert patient R0-status.Postoperative RT chemo-RT give within 5-6 week surgery case positive .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Oropharyngeal Neoplasms</mesh_term>
	<criteria>OPSCC one follow subinstitutions : base tongue , lateral pharyngeal wall , tonsil , glossotonsillar sulcus ; TNM stage III : T1 T2 N0 , M0 Within 2 week randomization , assess MultiDisciplinary Team ( MDT ) compose least head neck/ENT surgeon , oncologist , radiologist , radiotherapist , pathologist treatment naïve patient suitable either TOS IMRT base : CT contrast and/or MRI do within 4 week prior randomization Panendoscopy assessment transoral exposure resection . In case suspicious adenopathy , Diffusion Weighted MRI must perform N0 define node &lt; 1cm great diameter , 11.3cm great diameter accord DW MRI , &gt; 1.3 cm great diameter consider N1 ; Age 18 older ; ECOG Performance status ≤ 2 ; Availability biological material HPV/p16 test Study information Informed consent discuss surgeon radiooncologist sign patient . Within 2 week prior randomization : Baseline MDADI score available ; Adequate bone marrow function demonstrate neutrophils count &gt; 1,5 109 /L , platelet count &gt; 75 109 /L , WBC≥ 3.0 109 /L ; Prothrombin time ( PT ) international normalize ratio ( INR ) ≤ 1.2 Partial thromboplastin time ( PTT ) ≤ 1.2 time ULN Normal 12lead ECG ; Women child bear potential ( WOCBP ) must negative serum urine pregnancy test Patients childbearing / reproductive potential agree use adequate birth control measure . A highly effective method birth control define result low failure rate ( i.e . le 1 % per year ) use consistently correctly . Any previous anticancer therapy HNSCC ( chemo radiotherapy molecular target therapy ) ; Any active malignancy ( nonmelanoma skin cancer localize cervical cancer localize presume cured prostatic cancer ) within last 5 year ongoing systemic treatment Cancer contact internal and/or external carotid artery Extension cancer across midline baseoftongue Involvement &gt; 50 % soft palate cancer , require reconstruction free flap involvement soft palate require reconstruction free flap judge surgeon Cancer originate soft palate posterior pharyngeal wall Preexisting dysphagia related oropharyngeal cancer Any psychological , cognitive , familial , sociological geographical condition potentially hamper compliance study protocol , completion patient report measure followup schedule ; condition discuss patient registration trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>T1-T2 , N0 oropharyngeal carcinoma</keyword>
</DOC>